SCHEMBL16514824

SCHEMBL16514824

NC(=O)C=Cc1cccc(-c2cccc3cnc(Nc4ccc(N5CCC(O)C5)cc4)nc23)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 4/20 0.50
FGFR2 P21802 1/20 0.49
STAT6 P42226 2/20 0.48
JAK2 O60674 1/20 0.47
BRD4 O60885 1/20 0.47
PTK2 Q05397 1/20 0.47
MAPK10 P53779 4/20 0.43
JUN P05412 2/20 0.43
MAPK8 P45983 2/20 0.43
SYK P43405 2/20 0.43
CDK4 P11802 1/20 0.42
CCND1 P24385 1/20 0.42
CCND2 P30279 1/20 0.42
CCND3 P30281 1/20 0.42
LCK P06239 1/20 0.42
JAK3 P52333 1/20 0.42
FGFR1 P11362 1/20 0.41
KDR P35968 1/20 0.41
DCLK1 O15075 1/20 0.41
LRRK2 Q5S007 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19096959 0.87 MAPK10 (0.55) EGFRFGFR2STAT6JAK2BRD4
SCHEMBL16514597 0.84 TTK (0.56) EGFRFGFR2JAK2BRD4PTK2
SCHEMBL16513769 0.84 EGFR (0.57) EGFRFGFR2JAK2BRD4PTK2
SCHEMBL16514973 0.83 EGFR (0.52) EGFRFGFR2JAK2BRD4PTK2
SCHEMBL16513467 0.83 EGFR (0.58) EGFRFGFR2JAK2BRD4PTK2
SCHEMBL16514598 0.82 EGFR (0.74) EGFRFGFR2JAK2BRD4PTK2
SCHEMBL16514755 0.82 EGFR (0.47) EGFRFGFR2JAK2BRD4PTK2
SCHEMBL16514411 0.82 MAPK10 (0.47) EGFRFGFR2JAK2BRD4MAPK10
SCHEMBL29848075 0.82 EGFR (0.74) EGFRFGFR2JAK2BRD4PTK2
Fumaric Acid SCHEMBL16514713 0.81 FGFR2 (0.66) EGFRFGFR2JAK2BRD4PTK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3035936-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS NeuPharma, Inc. (US) 2016-06-29 EP disclosed
WO-2015027222-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS NEUPHARMA, INC. (US) 2015-02-26 WO disclosed